Uttar Pradesh Orders Free H1N1 Tests at Government Facilities
On 2 September 2026, Uttar Pradesh Chief Minister Yogi Adityanath directed government health institutions across the state to provide free Influenza A (H1N1) testing. The order followed a high-level review meeting on rising H1N1 and seasonal flu cases. Experts told the meeting that the state had recorded 685 laboratory-confirmed H1N1 cases as of that Wednesday.
Hospital readiness and treatment
Adityanath directed district hospitals, medical colleges and large government hospitals to prepare separate intensive care unit wards for serious H1N1 patients. He called for adequate supplies of Oseltamivir (Tamiflu), oxygen, ventilators, nebulisers, oxygen masks and testing kits. Surveillance and treatment systems are to be strengthened in districts reporting more cases. He also ordered strict action against private institutions and pathology laboratories that charge above government-prescribed H1N1 testing fees.
Screening and clinical guidance
All patients with Severe Acute Respiratory Illness (SARI) must undergo H1N1 testing. Adityanath called for intensive screening by auxiliary nurse midwives (ANMs), Accredited Social Health Activist (ASHA) workers and other health personnel to identify suspected cases. He also directed officials to issue detailed prevention and treatment guidelines immediately and make teleconsultation services effective.
Important Facts for Exams
- Subtype notation: H1N1 denotes an influenza A subtype with type-1 haemagglutinin and type-1 neuraminidase proteins in its viral envelope.
- Host-adapted strains: Human-adapted H1N1 strains circulate endemically in people and cause seasonal flu; other H1N1 strains are endemic in pigs or birds.
- Genetic reassortment: Influenza A viruses have segmented, negative-sense RNA genomes; reassortment can combine genetic material from different strains and alter viral traits.
- Antiviral mechanism: Oseltamivir inhibits neuraminidase, preventing sialic-acid cleavage and thereby blocking newly formed influenza virions from exiting infected cells.